Back to results
US 2021/0332099 A1Published application
Pharmaceutical preparation
AssigneeFerring International Center S.A.
InventorsIan COTTINGHAM, Daniel PLAKSIN, Richard Boyd WHITE
Life of this patent
Estimating the term…
Abstract
Preparations including recombinant FSH (rFSH).
Claims9
Recombinant follicle stimulating hormone (FSH) comprising α2,3- and α2,6-sialylation, produced or expressed in a human cell line, wherein from 5% to 20% of the total sialylation of the recombinant FSH is α2,6-sialylation.
A method of manufacturing recombinant follicle stimulating hormone (FSH) comprising α2,3- and α2,6-sialylation, the method comprising producing or expressing recombinant FSH in a human cell line, wherein the human cell line has been modified using an α2,3-sialyltransferase.
Dependencies are inferred from the claim text.